Published in Future Virology
Aim: SARS-CoV-2 is an emerging coronavirus that was discovered in China and rapidly spread throughout the world. The authors looked at nucleotide and amino acid variations in SARS-CoV-2 genomes, as well as phylogenetic and evolutionary events in viral genomes, in Iran. Materials & methods: All SARS-CoV-2 sequences that were publicly released betwee...
Published in Future Virology
In the study of Copur et al. , #bloodgroupO was found to be protective by 20% from the risk of developing #SARS-CoV-2 #infection in #healthcareworkers.
Published in Future Virology
As the cases of SARS-CoV-2 infection escalates, the essence of in-depth knowledge around acquired immunity and emergence of reinfection and reactivation have to be captured. While being a rare phenomenon, reinfection occurs as the result of diminishing protection conferred by antibodies, especially IgG. Reactivation is more concerned with the role ...
Published in Future Virology
Aim: To verify a SARS-CoV-2 rapid antigen test (RAT) compared with PCR. Materials & methods: Validation of RAT included 2295 subjects. Next matching of RAT with the PCR was checked in 13,852 subjects referred to PCR after being positive in RAT. Results: Sensitivity and specificity of RAT were 77.38 and 99.10%, respectively. A 74.60% of RAT positive...
Published in Future Virology
Published in Future Virology
The Belgium’s strategy against COVID-19 was partly based on mass screening performed with reverse-transcription PCR analysis performed on nasopharyngeal samples. Reverse-transcription PCR allows the detection of individuals infected by the virus. In addition, it provides semi quantitative results correlated to the quantity of virus present in the p...
Published in Future Virology
Published in Future Virology
The expression pattern of RNA deaminases determines the mutation and evolution of SARS-CoV-2.
Published in Future Virology
Infective endocarditis (IE) symptoms including fever, fatigue, dyspnea and myalgia are similar in COVID-19 findings. Therefore, the diagnosis of IE may be missed in patients with COVID-19. Co-existence with IE in COVID-19 is rarely reported. However, to our knowledge, only one case of septic pulmonary embolism in COVID-19 and IE was reported. Here,...
Published in Future Virology
Aim: Mutations in the SARS-CoV-2 spike (S) protein have dramatically changed the transmissibility and pathogenicity of the virus. Therefore, we studied the binding affinity of Omicron spike-receptor binding domain (S-RBD) with human ACE2 receptor. Materials & methods: We used pyDockWEB and HADDOCK 2.4 docking for our study. Results: Computational d...
